Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hetlioz
Marketing
Vanda sues FDA for right to promote off-label drug use
After the FDA rejected Hetlioz as a jet lag disorder treatment, Vanda Pharmaceuticals is pursuing a new route to establish the drug in the space.
Andrea Park
Apr 11, 2025 1:53pm
Cycle's 2nd hostile takeover bid in 5 months rejected by Vanda
Oct 14, 2024 3:18pm
Vanda gets $466M takeout bid from Cycle Pharma
Jun 6, 2024 10:10am
Supreme Court rejects Vanda's Hetlioz patent revival appeal
Apr 22, 2024 3:49pm
15 years later, Vanda secures another FDA nod for Fanapt
Apr 3, 2024 11:04am
Vanda scores courtroom win over FDA in records case
Mar 29, 2023 3:15pm
